These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 5925664)
1. Haloperidol and thioridazine in treatment of chronic schizophrenics. Prasad L; Townley MC Dis Nerv Syst; 1966 Nov; 27(11):722-6. PubMed ID: 5925664 [No Abstract] [Full Text] [Related]
2. A comparison of haloperidol and thioridazine HC1 in chronic treatment-resistant schizophrenics. Gonier T; Schiele BC; Vestre ND Behav Neuropsychiatry; 1970; 2(3):47-9 passim. PubMed ID: 4913152 [No Abstract] [Full Text] [Related]
3. A comparative trial of haloperidol and thioridazine: management of chronic schizophrenia. Weston MJ; Bentley R; Unwin A; Morris M; Harper MA Aust N Z J Psychiatry; 1973 Mar; 7(1):52-7. PubMed ID: 4579393 [No Abstract] [Full Text] [Related]
4. Proceedings: Comparison of the effect of oxypertine and thioridazine on sensorimotor activity in chronic schizophrenics (a controlled study). Remr J; Nekolová J; Heinzl Z Act Nerv Super (Praha); 1975; 17(4):213-4. PubMed ID: 3930 [No Abstract] [Full Text] [Related]
5. A double-blind comparison of haloperidol (Haldol) and thioridazine (Mellaril) in outpatient children. Claghorn JL Curr Ther Res Clin Exp; 1972 Dec; 14(12):785-9. PubMed ID: 4629817 [No Abstract] [Full Text] [Related]
6. Serum prolactin and clinical state during neuroleptic treatment and withdrawal. Laughren TP; Brown WA; Williams BW Am J Psychiatry; 1979 Jan; 136(1):108-10. PubMed ID: 758812 [No Abstract] [Full Text] [Related]
8. Haloperidol and thioridazine drug levels and clinical response in schizophrenia: comparison of gas-liquid chromatography and radioreceptor drug level assays. Smith RC; Baumgartner R; Burd A; Ravichandran GK; Mauldin M Psychopharmacol Bull; 1985; 21(1):52-8. PubMed ID: 3983338 [No Abstract] [Full Text] [Related]
9. Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients. Shvartsburd A; Sajadi C; Morton V; Mirabi M; Gordon J; Smith RC J Clin Psychopharmacol; 1984 Aug; 4(4):194-8. PubMed ID: 6470190 [TBL] [Abstract][Full Text] [Related]
10. Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population. Martin IC Acta Psychiatr Scand; 1975 Feb; 51(2):110-8. PubMed ID: 235189 [TBL] [Abstract][Full Text] [Related]
11. Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine. Gerlach J; Simmelsgaard H Psychopharmacology (Berl); 1978 Oct; 59(2):105-12. PubMed ID: 103110 [No Abstract] [Full Text] [Related]
12. Extended experience with t8ioridazine in the treatment of hospitalized adolescents. Rinsley DB Dis Nerv Syst; 1968 Jan; 29(1):36-7. PubMed ID: 5635745 [No Abstract] [Full Text] [Related]
13. Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study. Tsuang MM; Lu LM; Stotsky BA; Cole JO J Am Geriatr Soc; 1971 Jul; 19(7):593-600. PubMed ID: 4937658 [No Abstract] [Full Text] [Related]
14. A fulminant case of neuroleptic malignant syndrome. Teo SK; Lam KN; Chew WL Singapore Med J; 1994 Feb; 35(1):110-1. PubMed ID: 8009269 [TBL] [Abstract][Full Text] [Related]
15. A controlled comparison of haloperidol and fluphenazine in chronic treatment-resistant schizophrenics. Hall WB; Vestre ND; Schiele BC; Zimmermann R Dis Nerv Syst; 1968 Jun; 29(6):405-8. PubMed ID: 4877748 [No Abstract] [Full Text] [Related]
16. [On the results of treatment and complications during the use of haloperidol in patients with long-term schizophrenia]. Zolotnitskii RI; Kutsenok BM; Gastev MD Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(5):750-4. PubMed ID: 5363890 [No Abstract] [Full Text] [Related]
17. [Depot-neuroleptics in the treatment of schizophrenia]. Schipper JA Ned Tijdschr Geneeskd; 1971 Apr; 115(16):707-9. PubMed ID: 5551427 [No Abstract] [Full Text] [Related]
18. Motility, Parkinsonism, and prolactin with thiothixene and thioridazine. Crowley TJ; Hydinger-Macdonald M Arch Gen Psychiatry; 1981 Jun; 38(6):668-75. PubMed ID: 7247630 [TBL] [Abstract][Full Text] [Related]
19. Clinical experience with Melleril-Retard. Svestka J; Náhunek K Act Nerv Super (Praha); 1970; 12(3):245-6. PubMed ID: 5457439 [No Abstract] [Full Text] [Related]
20. Effects of neuroleptics on platelet monoamine oxidase activity. Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]